These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9875391)

  • 21. The inhibition of human cytomegalovirus (hCMV) protease by hydroxylamine derivatives.
    Smith DG; Gribble AD; Haigh D; Ife RJ; Lavery P; Skett P; Slingsby BP; Stacey R; Ward RW; West A
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3137-42. PubMed ID: 10560740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzothiadiazine dioxide human cytomegalovirus inhibitors: synthesis and antiviral evaluation of main heterocycle modified derivatives.
    Martinez A; Gil C; Castro A; Bruno AM; Pérez C; Prieto C; Otero J
    Antivir Chem Chemother; 2003 Mar; 14(2):107-14. PubMed ID: 12856922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and synthesis of monocyclic beta-lactams as mechanism-based inhibitors of human cytomegalovirus protease.
    Borthwick AD; Weingarten G; Haley TM; Tomaszewski M; Wang W; Hu Z; Bedard J; Jin H; Yuen L; Mansour TS
    Bioorg Med Chem Lett; 1998 Feb; 8(4):365-70. PubMed ID: 9871686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: potency and plasma stability.
    Borthwick AD; Exall AM; Haley TM; Jackson DL; Mason AM; Weingarten GG
    Bioorg Med Chem Lett; 2002 Jul; 12(13):1719-22. PubMed ID: 12067545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second-generation highly potent and selective inhibitors of the hepatitis C virus NS3 serine protease.
    Chen KX; Nair L; Vibulbhan B; Yang W; Arasappan A; Bogen SL; Venkatraman S; Bennett F; Pan W; Blackman ML; Padilla AI; Prongay A; Cheng KC; Tong X; Shih NY; Njoroge FG
    J Med Chem; 2009 Mar; 52(5):1370-9. PubMed ID: 19196021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel yeast cell-based assay to screen for inhibitors of human cytomegalovirus protease in a high-throughput format.
    Cottier V; Barberis A; Lüthi U
    Antimicrob Agents Chemother; 2006 Feb; 50(2):565-71. PubMed ID: 16436711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of a potent macrocyclic 1,6-naphthyridine anti-human cytomegalovirus (HCMV) inhibitors.
    Falardeau G; Lachance H; St-Pierre A; Yannopoulos CG; Drouin M; Bédard J; Chan L
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1693-5. PubMed ID: 15745823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
    Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
    J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The herpesvirus protease: mechanistic studies and discovery of inhibitors of the human cytomegalovirus protease.
    Flynn DL; Becker DP; Dilworth VM; Highkin MK; Hippenmeyer PJ; Houseman KA; Levine LM; Li M; Moormann AE; Rankin A; Toth MV; Villamil CI; Wittwer AJ; Holwerda BC
    Drug Des Discov; 1997 May; 15(1):3-15. PubMed ID: 9332827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel inhibitors of the hepatitis C virus NS3 proteinase.
    Bennett F; Liu YT; Saksena AK; Arasappan A; Butkiewicz N; Dasmahapatra B; Pichardo JS; Njoroge FG; Patel NM; Huang Y; Yang X
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4275-8. PubMed ID: 16087334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of the covalent modification of the catalytic triad of human cytomegalovirus protease by pseudo-reversible beta-lactam inhibitors and a peptide chloromethylketone.
    Haley TM; Angier SJ; Borthwick AD; Montgomery DS; Purvis IJ; Smart DH; Bessant C; Van Wely C; Hart GJ
    J Mass Spectrom; 1998 Dec; 33(12):1246-55. PubMed ID: 9875526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2-chloro-3-substituted-1,4-naphthoquinone inactivators of human cytomegalovirus protease.
    Ertl P; Cooper D; Allen G; Slater MJ
    Bioorg Med Chem Lett; 1999 Oct; 9(19):2863-6. PubMed ID: 10522707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New inhibitors of human cytomegalovirus (HCMV) on the horizon.
    De Clercq E
    J Antimicrob Chemother; 2003 May; 51(5):1079-83. PubMed ID: 12697653
    [No Abstract]   [Full Text] [Related]  

  • 34. Herpesvirus proteases: targets for novel antiviral drugs.
    Holwerda BC
    Antiviral Res; 1997 Jun; 35(1):1-21. PubMed ID: 9224957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles.
    Chen KX; Njoroge FG; Arasappan A; Venkatraman S; Vibulbhan B; Yang W; Parekh TN; Pichardo J; Prongay A; Cheng KC; Butkiewicz N; Yao N; Madison V; Girijavallabhan V
    J Med Chem; 2006 Feb; 49(3):995-1005. PubMed ID: 16451065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toward the Synthesis of Fluorinated Analogues of HCV NS3/4A Serine Protease Inhibitors Using Methyl α-Amino-β-fluoro-β-vinylcyclopropanecarboxylate as Key Intermediate.
    Milanole G; Andriessen F; Lemonnier G; Sebban M; Coadou G; Couve-Bonnaire S; Bonfanti JF; Jubault P; Pannecoucke X
    Org Lett; 2015 Jun; 17(12):2968-71. PubMed ID: 26053226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and antiviral evaluation of 2-substituted 4,5-dichloro- and 4,6-dichloro-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections.
    Zou R; Drach JC; Townsend LB
    J Med Chem; 1997 Feb; 40(5):802-10. PubMed ID: 9057867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzothiadiazine dioxide dibenzyl derivatives as potent human cytomegalovirus inhibitors: synthesis and comparative molecular field analysis.
    Martinez A; Gil C; Abasolo MI; Castro A; Bruno AM; Perez C; Prieto C; Otero J
    J Med Chem; 2000 Aug; 43(17):3218-25. PubMed ID: 10966740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antiviral activities of 3-aralkylthiomethylimidazo[1,2-b]pyridazine derivatives.
    Galtier C; Mavel S; Snoeck R; Andreï G; Pannecouque C; Witvrouw M; Balzarini J; De Clercq E; Gueiffier A
    Antivir Chem Chemother; 2003 Jul; 14(4):177-82. PubMed ID: 14582846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
    Johansson PO; Bäck M; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
    Bioorg Med Chem; 2006 Aug; 14(15):5136-51. PubMed ID: 16675222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.